Cargando…

Influence of phase correction of late gadolinium enhancement images on scar signal quantification in patients with ischemic and non-ischemic cardiomyopathy

BACKGROUND: Myocardial fibrosis imaging using late gadolinium enhancement (LGE) cardiac magnetic resonance (CMR) has been validated as a quantitative predictive marker for response to medical, surgical, and device therapy. To date, all such studies have examined conventional, non-phase corrected mag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stirrat, John, Joncas, Sebastien Xavier, Salerno, Michael, Drangova, Maria, White, James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4528363/ https://www.ncbi.nlm.nih.gov/pubmed/26248535 http://dx.doi.org/10.1186/s12968-015-0163-8

Ejemplares similares

Comparison of scar signal quantification using phase corrected and conventional magnitude inversion recovery delayed enhancement imaging in patients with ischemic and non-ischemic cardiomyopathy
por: Stirrat, John, et al.
Publicado: (2013)

Accuracy and reproducibility of semi-automated late gadolinium enhancement quantification techniques in patients with hypertrophic cardiomyopathy
por: Mikami, Yoko, et al.
Publicado: (2014)

Precision and reproducibility of semi-automated late gadolinium enhancement quantification techniques in patients with hypertrophic cardiomyopathy
por: Mikami, Yoko, et al.
Publicado: (2014)

High-resolution 3-dimensional late gadolinium enhancement scar imaging in surgically corrected Tetralogy of Fallot: clinical feasibility of volumetric quantification and visualization
por: Stirrat, John, et al.
Publicado: (2014)

Comparison of Semi-automated Late Gadolinium Enhancement Quantification Techniques in Measuring Septal Fibrosis in Patients with Dilated Non-Ischemic Cardiomyopathy
por: Mikami, Yoko, et al.
Publicado: (2016)

Objective criteria for septal fibrosis in non-ischemic dilated cardiomyopathy: validation for the prediction of future cardiovascular events
por: Mikami, Yoko, et al.
Publicado: (2016)

Prognostic value of late gadolinium enhancement in cardiac MRI of non-ischemic dilated cardiomyopathy patients
por: Behera, Dibya Ranjan, et al.
Publicado: (2020)

Influence of anterior mitral valve length and septal wall thickness on the prevalence of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy
por: Morant, Kareem, et al.
Publicado: (2012)

The Role of Circulating Collagen Turnover Biomarkers and Late Gadolinium Enhancement in Patients with Non-Ischemic Dilated Cardiomyopathy
por: Revnic, Radu, et al.
Publicado: (2022)

CMR - Late gadolinium enhancement characteristics associated with monomorphic ventricular arrhythmia in patients with non-ischemic cardiomyopathy
por: Rajinthan, Priyanka, et al.
Publicado: (2022)

Dark-Blood Late Gadolinium Enhancement MRI Is Noninferior to Bright-Blood LGE in Non-Ischemic Cardiomyopathies
por: Brendel, Jan M., et al.
Publicado: (2023)

Extracellular volume-guided late gadolinium enhancement analysis for non-ischemic cardiomyopathy: The Women’s Interagency HIV Study
por: Kato, Yoko, et al.
Publicado: (2021)

Ischemic and non-ischemic patterns of late gadolinium enhancement in heart failure with reduced ejection fraction
por: Matusik, Patrycja S., et al.
Publicado: (2021)

Impact of late gadolinium enhancement extent, location, and pattern on ventricular tachycardia and major adverse cardiac events in patients with ischemic vs. non-ischemic cardiomyopathy
por: Tat, Emily, et al.
Publicado: (2022)

Multiplanar 4D strain analysis with spatial mapping to 3D LGE quantification: relationships in chronic Ischemic Cardiomyopathy
por: Satriano, Alessandro, et al.
Publicado: (2015)

Overlapping Phenotypes and Degree of Ventricular Dilatation Are Associated with Severity of Systolic Impairment and Late Gadolinium Enhancement in Non-Ischemic Cardiomyopathies
por: Boban, Marko, et al.
Publicado: (2018)

High Sensitivity of Late Gadolinium Enhancement for Predicting Microscopic Myocardial Scarring in Biopsied Specimens in Hypertrophic Cardiomyopathy
por: Konno, Tetsuo, et al.
Publicado: (2014)

Quantification of late gadolinium enhanced CMR in viability assessment in chronic ischemic heart disease: a comparison to functional outcome
por: Beek, Aernout M, et al.
Publicado: (2009)

Jeopardized Myocardium Defined by Late Gadolinium Enhancement Magnetic Resonance Imaging Predicts Survival in Patients With Ischemic Cardiomyopathy: Impact of Revascularization
por: Kwon, Deborah H., et al.
Publicado: (2018)

Smoking aggravates ventricular arrhythmic events in non-ischemic dilated cardiomyopathy associated with a late gadolinium enhancement in cardiac MRI
por: Park, Junbeom, et al.
Publicado: (2018)

Implications of multiple late gadolinium enhancement lesions on the frequency of left ventricular reverse remodeling and prognosis in patients with non‐ischemic cardiomyopathy
por: Ota, Shingo, et al.
Publicado: (2021)

Association of Whole-Heart Myocardial Mechanics by Transthoracic Echocardiography with Presence of Late Gadolinium Enhancement by CMR in Non-Ischemic Dilated Cardiomyopathy
por: Mėlinytė-Ankudavičė, Karolina, et al.
Publicado: (2022)

Segmental late gadolinium enhancement and gadolinium extracellular volume in hypertrophic cardiomyopathy
por: Levine, Jonathan M, et al.
Publicado: (2016)

Improved Quantification of Myocardium Scar in Late Gadolinium Enhancement Images: Deep Learning Based Image Fusion Approach
por: Fahmy, Ahmed S., et al.
Publicado: (2021)

Comparison of fast multi-slice and standard segmented techniques for detection of late gadolinium enhancement in ischemic and non-ischemic cardiomyopathy – a prospective clinical cardiovascular magnetic resonance trial
por: Muehlberg, Fabian, et al.
Publicado: (2018)

Additive prognostic value of red cell distribution width over late gadolinium enhancement on CMR in patients with non-ischemic dilated cardiomyopathy
por: Yi, Jeong-Eun, et al.
Publicado: (2020)

Improvement of late gadolinium enhancement image quality using a deep learning–based reconstruction algorithm and its influence on myocardial scar quantification
por: van der Velde, Nikki, et al.
Publicado: (2020)

Microvascular ischemia in hypertrophic cardiomyopathy: new insights from high-resolution combined quantification of perfusion and late gadolinium enhancement
por: Villa, Adriana D. M., et al.
Publicado: (2016)

Mean Scar Entropy by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Associated With Ventricular Arrhythmias Events in Hypertrophic Cardiomyopathy
por: Ye, Yang, et al.
Publicado: (2021)

Late gadolinium enhancement score (LGE-Score) for prediction of extensive late gadolinium enhancement in hypertrophic cardiomyopathy
por: Chan, Raymond H, et al.
Publicado: (2015)

Free-breathing 3D phase-sensitive inversion recovery late gadolinium enhancement at 3.0 Tesla: reliability and image quality in ischemic and non-ischemic cardiomyopathy in comparison with multiple breath-hold 3D imaging
por: Bizino, Maurice, et al.
Publicado: (2015)

Late gadolinium enhancement by cardiac magnetic resonance imaging predicts reverse remodeling in patients with non-ischemic cardiomyopathy receiving β blocker therapy
por: Kida, Keisuke, et al.
Publicado: (2011)

Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy
por: Aquaro, Giovanni Donato, et al.
Publicado: (2010)

Exuberant Pattern of Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy
por: Fernandes, Elsa, et al.
Publicado: (2013)

Diagnostic and prognostic role of late gadolinium enhancement in cardiomyopathies
por: Aquaro, Giovanni Donato, et al.
Publicado: (2023)

Quantification of myocardial scar assessed by late gadolinium enhancement CMR in the multi-ethnics study of atherosclerosis: comparisons of 7 different methods
por: Rizzi, Patricia B, et al.
Publicado: (2013)

Histopathological validation of semi-automated myocardial scar quantification techniques for dark-blood late gadolinium enhancement magnetic resonance imaging
por: Nies, Hedwig M J M, et al.
Publicado: (2022)

Distinct non-ischemic myocardial late gadolinium enhancement lesions in patients with type 2 diabetes
por: Bojer, Annemie Stege, et al.
Publicado: (2020)

Prognostic implications of late gadolinium enhancement at the right ventricular insertion point in patients with non-ischemic dilated cardiomyopathy: A multicenter retrospective cohort study
por: Yi, Jeong-Eun, et al.
Publicado: (2018)

Detection of intramural scar by electroanatomic mapping versus MRI in patients with non-ischemic cardiomyopathy
por: Desjardins, Benoit, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_52npo7qognisj73n2846cu5pp0